Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. (Prolectin-M)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04512027
Recruitment Status : Completed
First Posted : August 13, 2020
Last Update Posted : October 19, 2020
Sponsor:
Collaborator:
Pharmalectin Inc
Information provided by (Responsible Party):
Composite Interceptive Med Science

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 19, 2020
Actual Study Completion Date : October 16, 2020